Features | Partner Sites | Information | LinkXpress
Sign In
Ampronix
GLOBETECH PUBLISHING LLC
Schiller

Robotic Bladder Surgery Fails to Cut Complications

By HospiMedica International staff writers
Posted on 07 Aug 2014
Robot-assisted and open cystectomy led to similar complication rates among patients with invasive bladder cancer, according to a new study.

Researchers at Memorial Sloan Kettering Cancer Center (MSKCC; New York, NY, USA) conducted a prospective, randomized clinical trial to compare open and robot-assisted laparoscopic cystectomy in 118 patients with newly diagnosed invasive bladder cancer. All surgeries were performed by the same seven surgeons, four experienced in open technique and three with extensive background in robot-assisted cystectomy. The primary outcome was complication rate during the first 90 days after surgery, as defined in accordance with the Clavien grading system.

During the study, 58 patients were randomized to open cystectomy and 60 to robot-assisted laparoscopic cystectomy. Subsequently, four patients in the robotics group refused randomized treatment and underwent open cystectomy. The results showed that 90-day complication rate was 62% with robotic surgery and 66% with open surgical resection of the bladder, with a similar proportion of severe complications. Enrollment stopped when an interim analysis showed that outcomes at that point met predefined criteria for futility. The study was published in the July 24, 2014, issue of the New England Journal of Medicine (NEJM).

“Because the trial was performed by experienced surgeons at a single, high-volume referral center, the results may not be generalizable to all clinical settings,” concluded lead author Bernard Bochner, MD, and colleagues. “Nonetheless, these results highlight the need for randomized trials to inform the benefits and risks of new surgical technologies before widespread implementation.”

Radical cystectomy remains standard of care for non-metastatic, invasive bladder cancer. However, the procedure often leads to clinically significant perioperative complications, exacerbated by older age, comorbidities, and other patient characteristics. Not uncommonly, patients require an extended recovery period.

Related Links:

Memorial Sloan Kettering Cancer Center



Harloff
Inditherm
JD Honigberg International

Channels

Critical Care

view channel

Little Evidence Supports Opioid Use for Chronic Pain

A new study reveals that there is paltry evidence for the long-term safety and efficacy of opioids in the treatment of chronic pain. Researchers at the Oregon Health & Science University (OHSU; Portland, USA) and the University of Washington (Seattle, USA) searched MEDLINE, the Cochrane Central Register of Controlled... Read more

Women's Health

view channel

Pregnant Women in Austria Experience Iodine Deficiency

A new study suggests that pregnant women in Austria have a potentially clinically significant iodine deficiency which could impair embryonic brain development. Researchers at the Medical University of Vienna (Austria) conducted a cross-sectional investigation of urinary iodine excretion in 246 pregnant women (2 in the... Read more

Health IT

view channel

Computer Model Predicts Public Response to Disease Outbreaks

A new computer model could help public health officials anticipate public reactions to disease outbreaks, based on a combination of data collected from hospitals, social media, and other sources. Researchers at MIT (Cambridge, MA, USA), the Draper Laboratory (Cambridge, MA, USA), and Ascel Bio (Larchmont, NY, USA),... Read more

Business

view channel

Abbott Completes Topera Acquisition

Abbott (Abbott Park, IL, USA) has completed its acquisition of Topera (Menlo Park, CA, USA), developer of innovative electrophysiology technologies for the diagnosis and treatment of atrial fibrillation (AF). The Topera rotor identification system helps physicians identify and target patient-specific rotors that have... Read more
 

Events

05 Mar 2015 - 08 Mar 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.